PT Itama Ranoraya Tbk Stock price

Equities

IRRA

ID1000151707

Medical Equipment, Supplies & Distribution

End-of-day quote INDONESIA S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
560 IDR -1.75% Intraday chart for PT Itama Ranoraya Tbk +13.82% -30.00%
Sales 2021 1,320B 83.14M Sales 2022 754B 47.48M Capitalization 1,688B 106M
Net income 2021 112B 7.07M Net income 2022 48B 3.02M EV / Sales 2021 2.35 x
Net cash position 2021 55.29B 3.48M Net Debt 2022 43.42B 2.74M EV / Sales 2022 2.3 x
P/E ratio 2021
27 x
P/E ratio 2022
35.2 x
Employees 209
Yield 2021
0.95%
Yield 2022
-
Free-Float 13.91%
More Fundamentals * Assessed data
Dynamic Chart
PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
PT Itama Ranoraya Tbk entered into a conditional share purchase agreement to acquire a 51% stake in PT Oneject Indonesia. CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2021 CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2020 CI
PT Itama Ranoraya Tbk's Equity Buyback announced on March 12, 2020, has expired with 113,622,400 shares, representing 7.1% for IDR 59,914.1 million. CI
More news
1 day-1.75%
1 week+13.82%
Current month+12.90%
1 month+6.67%
3 months-27.27%
6 months+9.80%
Current year-30.00%
More quotes
1 week
520.00
Extreme 520
670.00
1 month
480.00
Extreme 480
670.00
Current year
462.00
Extreme 462
815.00
1 year
436.00
Extreme 436
1 045.00
3 years
436.00
Extreme 436
2 280.00
5 years
350.00
Extreme 350
4 390.00
10 years
350.00
Extreme 350
4 390.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 -
Comptroller/Controller/Auditor 37 20-03-31
Corporate Officer/Principal 60 20-12-31
Members of the board TitleAgeSince
Director/Board Member 59 21-12-31
Corporate Secretary 61 18-12-31
Chairman 69 20-11-12
More insiders
Date Price Change Volume
24-03-28 560 -1.75% 10,910,100
24-03-27 570 +7.55% 44,649,000
24-03-26 530 -4.50% 6,090,200
24-03-25 555 -9.76% 51,207,500
24-03-22 615 +25.00% 48,386,900

End-of-day quote INDONESIA S.E., March 27, 2024

More quotes
PT Itama Ranoraya Tbk is an Indonesia-based healthcare company, which is engaged in offering healthcare solutions. The Company operates in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. The Company carries out its operations through four products, namely the non-electromedical sterile medical devices, in-vitro diagnostic, electromedical sterile medical devices, and other products. Its business segment focuses on in-vitro diagnostic (IVD), medical imaging, surgical instrument and disposable, critical care, blood banking and transfusion, cardiovascular, brain management, cancer, urology, and maternal and neonatal care. Its products include Oneject, Abbott, Terumo, Becton Dickinson (BD), HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue.
More about the company
  1. Stock
  2. Equities
  3. Stock PT Itama Ranoraya Tbk - INDONESIA S.E.